Table 1 Immunohistochemical detection of MRD in Bone marrow after cladribine (Adapted from Ellison, DJ, Blood, 1994).
Months post-therapy | Positive N (%) | Indeterminant N (%) | Negative N (%) |
|---|---|---|---|
3–4 | 18 (47) | 19 (50) | 1 (3) |
5–7 | 17 (51) | 11 (39) | 0 |
8–10 | 9 (53) | 7 (41) | 1 (6) |
11–13 | 20 (43) | 25 (53) | 2 (4) |
14–16 | 5 (50) | 5 (50) | 0 |
17–25 | 10 (56) | 6 (33) | 2 (11) |
